ProQuest has acquired U.K.-based Pi2 Solutions, an industry leader in product literature databases, workflow tools and related outsourcing services for global pharmaceutical companies. The company plans to align Pi2 with its ProQuest Dialog corporate information service to create an integrated solution for pharmacovigilance and expand ProQuest’s presence in the pharmaceutical industry.
“Bringing together the market-leading tools of ProQuest Dialog and Pi2 creates a compelling new way to streamline the critical drug safety workflow of our pharmaceutical customers,” said Tim Wahlberg, ProQuest senior vice-president and General Manager, ProQuest Dialog. “ProQuest Dialog and Pi2 have an existing partnership and common customers, who have expressed interest in tighter integration between these tools. This is a great example of ProQuest’s ongoing effort to develop solutions that combine content, software tools and services in one place.”
Currently, pharmaceutical companies rely on ProQuest Dialog to monitor scientific literature for advances and news on drugs and therapies through alerts. They can then use Pi2’s Drug Safety Triager and related services to automate the review, categorization, and indexing of alert results. These results then flow into Pi2’s PinPoint product — a customized repository that offers market-leading search and content management functionality and delivers necessary regulatory reports.
To read the entire press release, click here.